Initial and accrued damage as predictors of mortality in Brazilian patients with systemic lupus erythematosus: a cohort study

Abstract

The aim of this study was to investigate whether initial and accrued organ damage measured by Systemic Lupus International Collaborating Clinics (SLICC) Damage Index (SDI) predicts mortality in cohort of Brazilian patients with systemic lupus erythematosus (SLE). One hundred and five outpatients with SLE were enrolled from July 2000 to March 2001; their demographics, disease manifestations, interventions and quantified disease activity (SLEDAI) were obtained. SDI was measured at baseline and at the end of follow-up. Initial and accrued SDI prognostic values for mortality were investigated by multivariate Cox survival analysis and Kaplan-Meyer survival curves. After a median follow-up of 6.3 years, 19 patients died due to disease activity, end-organ failure, cardiovascular events, cancer and infection. Deceased patients had longer disease duration and greater initial and final SDI than survivors had. After adjustment for age, sex and disease duration, both initial and final SDI ≥ 3 points were independent predictors of mortality, with hazard ratios (HRs) of 3.0 (1.1–8.2) and 4.7 (1.6–14.5), respectively. Damage accrual during follow-up was the strongest predictor of death (HR: 5.1, 2.0–13.0). Renal and pulmonary damages were the main predictors of increased mortality risk. In conclusion, baseline and accrued damage increase mortality risk in Brazilian patients with SLE. Measures to prevent damage development and progression are urgent to reduce the mortality of patients with SLE.

Keywords

Key words: damage mortality systemic lupus erythematosus

Get full access to this article

View all access options for this article.

References

1 Stahl-Hallengren C Jonsen A Nived O Sturfelt G . Incidence studies of systemic lupus erythematosus in Southern Sweden: increasing age, decreasing frequency of renal manifestations and good prognosis. J Rheumatol 2000; 27: 685–691.

2 Bernatsky S Boivin JF Joseph L . Mortality in systemic lupus erythematosus. Arthritis Rheum 2006; 54: 2550–2557.

3 Nossent J Cikes N Kiss E . Current cause of death in systemic lupus erythematosus in Europe, 2000–2004: relation to disease activity and damage accrual. Lupus 2007; 16: 309–317.

4 Stoll T Seifert B Isenberg DA . SLICC/ACR damage index is valid, and renal and pulmonary organ scores are predictors of severe outcome in patients with systemic lupus erythematosus. Br J Rheumatol 1996; 35: 248–254.

5 Rahman P Gladman DD Urowitz MB Hallet D Tam LS . Early damage as measured by the SLICC/ACR damage index is a predictor of mortality in systemic lupus erythematosus. Lupus 2001; 10: 93–96.

6 Alarcon GS McGwin G Bastian HM . Systemic lupus erythematosus in three ethnic groups. VIII. Predictors of early mortality in the LUMINA cohort. Arthritis Rheum 2001; 45: 191–202.

7 Nived O Jönsen A Bengtsson AA Bengtsson C Sturfelt G . High predictive value of the systemic lupus erythematosus international collaborating clinics/American college of rheumatolgy damage index for survival in systemic lupus erythematosus. J Rheumatol 2002; 29: 1398–1400.

8 Soares M Reis L Papi JAS Cardoso CRL . Rate, pattern and related factors to damage in Brazilian systemic lupus erythematosus patients. Lupus 2003; 12: 788–794.

9 Tan EM Cohen AS Fries JF . The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271–1277.

10.

10 Hochberg MC . Updating the American college of rheumatology revised criteria for classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1745.

11.

11 Gladman D Ginzler E Goldsmith C . The development and initial validation of the systemic lupus international collaborating clinics/American college of rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996; 39: 363–369.

12.

12 Gladman D Urowitz MB Goldsmith C . The reliability of the systemic lupus international collaborating clinics/American College of rheumatology damage index in patients with systemic lupus erythematosus. Arthritis Rheum 1997; 40: 809–813.

13.

13 Bombardier C Gladman DD Urowitz MB Caron D Chang CH . Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 1992; 35: 630–640.

14.

14 Concato J Feinstein AR Holford TR . The risk of determining risk in multivariate models. Ann Intern Med 1993; 118: 201–210.

15.

15 Cervera R Khamashta MA Font J . Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort with 1,000 patients. Medicine (Baltimore) 2003; 82: 299–308.

16.

16 Mok CC Mak A Chu WP To CH Wong SN . Long-term survival of southern Chinese patients with systemic lupus erythematosus: a prospective study of all age-groups. Medicine (Baltimore) 2005; 84: 218–224.

17.

17 Moss KE Ioannou Y Sultan SM Haq I Isenberg DA . Outcome of a cohort of 300 patients with systemic lupus erythematosus attending a dedicated clinic for over two decades. Ann Rheum Dis 2002; 61: 409–413.

18.

18 Manger K Manger B Repp R . Definition of risk factors for death, end stage renal disease, and thromboembolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus. Ann Rheum Dis 2002; 61: 1065–1070.

19.

19 Gladman DD Goldsmith CH Urowitz MB . The SLICC/ACR damage index for systemic lupus erythematosus international comparison. J Rheumatol 2000; 27: 373–376.

20.

20 Voss A Green A Junker P . Systemic lupus erythematosus in Denmark: clinical and epidemiological characterization of a country–based cohort. Scand J Rheumatol 1998; 27: 98–105.

21.

21 Mok CC Ho CT Wong RW Lau CS . Damage accrual in southern Chinese patients with systemic lupus erythematosus. J Rheumatol 2003; 30: 1513–1519.

22.

22 Pineau CA Bernatsky S Abrahamowicz M . A comparison of damage accrual across different calendar periods in systemic lupus erythematosus patients. Lupus 2006; 15: 590–594.

23.

23 Becker-Merok A Nossent HC . Damage accumulation in systemic lupus erythematosus and its relation to disease activity and mortality. J Rheumatol 2006; 33: 1570–1577.

24.

24 Mody G Parag K Nathoo B . High mortality with systemic lupus erythematosus in hospitalized African blacks. Br J Rheumatol 1994; 33: 1151–1153.

25.

25 Samanta A Feehally J Roy S . High prevalence of systemic disease and mortality in Asian subjects with systemic lupus erythematosus. Ann Rheum Dis 1991; 50: 490–492.

26.

26 Mackenbach JP Kunst AE Groenhof F . Socioeconomic inequalities in mortality among men and women: an international study. Am J Public Health 1999; 89: 1800–1806.

27.

27 Krishnan E . Hospitalization and mortality of patients with systemic lupus erythematosus. J Rheumatol 2006; 33: 1770–1774.

28.

28 Duran S Apte M Alarcon GS . LUMINA Study Group. Poverty, not ethnicity accounts for the differential mortality rates among lupus patients of various ethnic groups. J Natl Med Assoc 2007; 99: 1196–1198.

29.

29 Blanco FJ Gomez-Reino JJ de la Mata J . Survival analysis of 306 patients European Spanish patients with systemic lupus erythematosus. Lupus 1998; 7: 159–163.

30.

30 Kasitanon N Magder LS Petri M . Predictors of survival in systemic lupus erythematosus. Medicine (Baltimore) 2006; 85: 147–156.